Xiromed debuts generic Librax
Librax capsules and its generics had a market value of $100.5 million for the 12 months ended February 2021, according to IQVIA.
Patients with such stomach or intestinal disorders as ulcers, irritable bowel syndrome, bowel infections, have a new generic drug.
Xiromed is offering chlordiazepoxide HCl and clidinium bromide capsules.
The product is the generic of Bausch Health’s Librax.
“The launch of chlordiazepoxide HCl and clidinium bromide capsules is the latest addition to Xiromed’s robust portfolio of generic pharmaceutical products and demonstrates our commitment to offering affordable generics to the US market,” said Xiromed CEO, Narasimhan Mani.
Librax capsules and its generics had a market value of $100.5 million, for the 12 months ending February 2021, according to IQVIA.